期刊文献+

某三甲妇儿专科医院注射用A型肉毒毒素处方分析 被引量:2

Prescription analysis of botulinum toxin type A for injection in a women and children's hospital
下载PDF
导出
摘要 目的分析我院门诊及住院处方使用注射用A型肉毒毒素的特点,讨论A型肉毒毒素临床实际应用情况,为临床合理用药提供依据。方法统计分析我院2013-2016年门诊及住院注射用A型肉毒毒素处方。结果 342张注射用A型肉毒毒素处方中,女306例,占89.47%,男36例,占10.53%,其中医学美容科女性比例高于男性,而康复医学科男性比例高于女性;患者临床诊断分布情况:医学美容科主要为面部皱纹整容(40.05%)及下颌角肥大伴咬肌肥大(26.90%),康复医学科主要为痉挛型脑性瘫痪(9.06%)。结论我院注射用A型肉毒毒素在医学美容科主要用于面部皱纹整容、咬肌肥大、腓肠肌肥大、局限性多汗、腋臭、眼睑松弛等;康复医学科主要用于痉挛型脑性瘫痪,其他科室(内科及外科)主要用于面肌痉挛,肉毒毒素属于医疗用毒性药品,临床应用领域广泛,合理使用A型肉毒毒素至关重要。 Objective To analyze the characteristics of botulinum toxin type A used in outpatient and inpatient prescriptions, and to discuss the clinical application of botulinum toxin type A, so as to provide evidence for rational drug use in clinics. Methods The date of the use of botulinum toxin type A from 2013 to 2016 in our hospital were summarized and analyzed in clinics. Results Among the 342 prescriptions for botulinum toxin type A, 306 were for female,accounting for 89. 47% ,and 36 were for male,accounting for 10. 53%. Among them,the proportion of women in medical cosmetology was higher than that in men, while the proportion of males in rehabilitation medicine was higher than that in females. The main diagnosis of medical cosmetic department was cosmetic operation of facial wrinkles (40. 05% ) and mandibular angle hypertrophy with masseteric hypertrophy (26. 90% ), and that of rehabilitation medi- cine department was spastic cerebral plasy (9.06%). Conclusion In our hospital the injection of botulinum toxin A in medical cosmetology department is mainly used for cosmetic operation of facial wrinkles, masseteric hypertrophy, gastrocnernius hypertrophy, regional hyperhidrosis, bromhidrosis, baggy eyelid and so on. In rehabilitation medicine de- partment it is mainly used for spastic cerebral palsy,and in other departments (medical and surgical) it is mainly used for hemifacial spasm. Botulinum toxin belongs to the medical toxic medicine and has a wide range of clinical applica- tions. It is important to use botulinum toxin A rationally.
出处 《实用药物与临床》 CAS 2017年第7期829-831,共3页 Practical Pharmacy and Clinical Remedies
关键词 注射用A型肉毒毒素 处方 分析 Botulinum toxin type A for injection Prescription Analysis
  • 相关文献

参考文献3

二级参考文献35

  • 1于建敏,王艳,宋红平.A型肉毒毒素加强法治疗面肌痉挛[J].中国神经免疫学和神经病学杂志,2003,10(3):190-190. 被引量:9
  • 2吴晓红,李伯达,黄惠铭.睑袋整形术联合应用A型肉毒毒素治疗鱼尾纹[J].中国美容医学,2005,14(4):452-452. 被引量:3
  • 3Gagliardi A,Jadad AR. Examination of instruments used to rate quality of health information on the internet:chronicle of a voyage with an unclear destination[J].{H}BMJ:British Medical Journal,2002.569-573.
  • 4Cohen BL,Barboglio P,Rodriguez D. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder:100 versus 150 units[J].{H}Neurourology and Urodynamics,2009.205-208.
  • 5Cruz F,Herschorn S,Aliotta P. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity:a randomised,double-blind,placebo-controlled trial[J].{H}EUROPEAN UROLOGY,2011.742-750.
  • 6Dmochowski RR,Newman DK,Sand PK. Pharmacokinetics of oxybutynin chloride topical gel:effects of application site,baths,sunscreen and person-to-person transference[J].Clin Drug Investig,2011.559-571.
  • 7Ehren 1,Volz D,Farrelly E. Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity:a randomised,placebo-controlled,double-blind study[J].{H}SCANDINAVIAN Journal OF UROLOGY AND NEPHROLOGY,2007.335-340.
  • 8Flynn MK,Amundsen CL,Perevich M. Outcome of a randomized,double-blind,placebo controlled trial of botulinum A toxin for refractory overactive bladder[J].{H}Journal Of Urology,2009.2608-2615.
  • 9Herschorn S,Gajewski J,Ethans K. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence:a randomized,double-blind trial[J].{H}Journal Of Urology,2011.2229-2235.
  • 10Kuo HC. Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity[J].{H}Neurourology and Urodynamics,2011.1497-1502.

共引文献17

同被引文献14

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部